Clinical Trial: A Safety, Tolerability, Pharmacokinetics/Pharmacodynamics Study of HEC169584 Capsules in Healthy Subjects

U.S., Aug. 2 -- ClinicalTrials.gov registry received information related to the study (NCT07099118) titled 'A Safety, Tolerability, Pharmacokinetics/Pharmacodynamics Study of HEC169584 Capsules in Healthy Subjects' on July 18.

Brief Summary: The safety, tolerability, and pharmacokinetic/pharmacodynamic (PK/PD) characteristics study of HEC169584 capsules in healthy subjects .

Study Start Date: Aug. 14

Study Type: INTERVENTIONAL

Condition: Non - Alcoholic Steatohepatitis

Intervention: DRUG: HEC169584 capsule

Each dose of HEC83518 will be administered with approximately 240 mL of water in the morning after fasting for at least 10 hours overnight.

DRUG: placebo

The placebo will be administered with approximately 240 mL of water in the...